Scholarly publications and presentations by Rochester Regional Health's Oncology and Hematology department authors.

Follow


Submissions from 2025

Link

6-10-2025          Unravelling VEXAS syndrome: shedding light on a recently recognised medical condition, Syeda Sarah Raza, Abdullah A. Orakzai, Rochester Regional Health, Ahmed Salman, Rochester Regional Health, et al.

Link

6-1-2025          Diagnosis of Duffy Null-Associated Neutropenia During Chemotherapy, Zeni Kharel, Rochester Regional Health, Nicole Jean Rubin, Rochester Regional Health, Rachel David, Rochester Regional Health, et al.

Link

6-1-2025          Exploring hidden risk: The prevalence of humoral immunodeficiency in patients with lymphoproliferative disorders—A prospective study, Hassan Saeed, Rochester Regional Health, Syed Usman Mohsin Ehsanullah, Rochester Regional Health, Mouna Reghis, Rochester Regional Health, et al.

Link

6-1-2025          Outcomes and prognostic factors in breast cancer patients with leptomeningeal metastasis: Insights from a retrospective analysis, Zauraiz Anjum, Rochester Regional Health, Sugam Gouli, Rochester Regional Health, Mahrukh Tariq, et al.

Link

6-1-2025          Spot Urine Protein/Creatinine Ratio as an Alternative to 24-Hour Urine Collection for Measuring Proteinuria in Patients With Multiple Myeloma: A Prospective Study, Saad Jamshed, Rochester Regional Health, Mohammad Ammad-Ud-Din, Rochester Regional Health, Kimberly Celotto, et al.

5-1-2025          Unveiling a 25-Year Journey: The Story of an Acquired Hemophilia Patient, Zeni Kharel, Rochester Regional Health; Mukul Singal, Indiana Hemophilia and Thrombosis Center, Indianapolis, Indiana.; and Ronald L. Sham, Rochester Regional Health

Link

4-28-2025          Babesiosis unmasked in chronic lymphocytic leukemia: A case report, Himal Kharel, Rochester Regional Health; Zeni Kharel, Rochester Regional Health; and Pradyumna D. Phatak, Rochester Regional Health

4-1-2025          Plasmacytoma and Amyloidoma Presenting as an Iliac Mass, Zeni Kharel, Rochester Regional Health, Sungeun Kim, Rochester Regional Health, Roman M. Kowalchuk, Rochester Regional Health, et al.

File

3-20-2025          Unseen Hurdles in Cancer Care, Purva Shah, Rochester Regional Health and Robin M. Reid, Rochester Regional Health

File

2-27-2025          Elevated and Unexplained: Navigating Erythrocytosis and Thrombocytosis, Aniket-Vijay Rao, Rochester Regional Health and Peter A. Kouides, Rochester Regional Health

Link

2-1-2025          Efficacy of PD-1 inhibitor plus chemotherapy versus chemotherapy in advanced esophageal carcinoma: A meta-analysis of phase III clinical trials, Zauraiz Anjum, Rochester Regional Health, Helai Hussaini, Shobha Mandal, et al.

Link

2-1-2025          Efficacy of pembrolizumab in advanced esophageal carcinoma: A systematic review and meta-analysis, Helai Hussaini, Zauraiz Anjum, Rochester Regional Health, Shobha Mandal, et al.

File

1-16-2025          Thrombotic Microangiopathies, Ahmed Salman, Rochester Regional Health

Link

1-1-2025          Barriers to participation in clinical trials of rural older adult cancer survivors: A qualitative study, Evelyn Arana-Chicas, Division of Medical Oncology, Rutgers Cancer Institute of NJ, Rutgers University, New Brunswick, New Jersey, USA., Laura M. Prisco, Geriatric Oncology Research Group, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA., Saloni Sharma, Geriatric Oncology Research Group, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA., et al.

Link

1-1-2025          Clinical Spectrum and Treatment Outcomes of Rare Bleeding Disorders in Female Patients: A Two-Center Experience in North Pakistan, Muhammad Usman, Nighat Shahbaz, Mehreen Ali Khan, et al.

Link

1-1-2025          Survival and Chemotherapy Response in Metastatic Lung Carcinoids: Insights from the National Cancer Database, Niraj Neupane, Rochester Regional Health, Sumeet K. Yadav, Elham Moases Ghaffary, et al.

Submissions from 2024

File

12-5-2024          The Whole Person: Addressing Spiritual Care in Serious Illness, Jonathan Steiner, Rochester Regional Health

Link

12-1-2024          Detrimental Impact of Chemotherapy Dose Reduction or Discontinuation in Early Stage Triple-Negative Breast Cancer Treated With Pembrolizumab and Neoadjuvant Chemotherapy: A Multicenter Experience, Jayasree Krishnan, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Archit Patel, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Arya Mariam Roy, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY., et al.

Link

12-1-2024          Efficacy of trastuzumab deruxtecan in treating HER2-low breast cancer leptomeningeal metastasis: a case report, Zeni Kharel, Rochester Regional Health, Sarah Stanford, Department of Chemistry, Xavier University of Louisiana, New Orleans, LA 70125, USA., Lauryn E. Hemminger, Department of Neurology, University of Rochester Medical Center, NY 14642, USA., et al.

Link

11-28-2024          Anaplasmosis, Zeni Kharel, Rochester Regional Health and Sungeun Kim, Rochester Regional Health

Link

11-5-2024          Association of Palliative Care Involvement and Infectious Complications in Hospitalized Multiple Myeloma Patients - National Inpatient Database Study, Purva Shah, Rochester Regional Health, Basant Eltaher, Rochester Regional Health, Amir Mahmoud, et al.

Link

11-5-2024          Comparing Anticoagulation Strategies in Left Ventricular Assist Devices - Direct Oral Anticoagulants, No Anticoagulation, and Warfarin: A Case Series and Systematic Review of Literature, Tripti Jain, Rochester Regional Health; Harkarandeep Singh, Rochester Regional Health; and Peter A. Kouides, Rochester Regional Health

Link

11-5-2024          Hemophagocytic Lymphohistiocytosis in Pregnancy, a Systematic Review of Case Reports and Case Series, Ali Abdelhay, Rochester Regional Health, Basant Eltaher, Rochester Regional Health, Mouna Reghis, Rochester Regional Health, et al.

Link

11-1-2024          Successful 13-year ongoing remission with C5 inhibitor therapy following renal transplant in atypical hemolytic uremic syndrome, Mariam A. Mostafa, Rochester Regional Health, Martin Zand, University of Rochester, Rochester, New York, USA., Jeremy Taylor, University of Rochester, Rochester, New York, USA., et al.

File

10-3-2024          MGUS Everywhere: What Does it Mean and What to do About it, Adam Starr, Rochester Regional Health